Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.905
-0.035 (-1.80%)
Oct 8, 2026, 1:08 PM EDT - Market open
Inhibikase Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +162.47% | Sep 15, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +319.95% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 | Buy | Maintains | $5 | +162.47% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +319.95% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $6 | Buy | Maintains | $6 | +214.96% | Jul 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $4 | Buy | Maintains | $4 | +109.97% | May 19, 2026 |